Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Cellular and Infection Microbiology|September 26, 2022
Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021Zongdan Jiang, Xuetian Qian, Zhi Wang, et al.
Oncology Letters|March 29, 2021
MicroRNA-365b-3p represses the proliferation and promotes the apoptosis of non-small cell lung cancer cells by targeting PPP5CXiaomiao Zhang, Jin Wang, Yuqin Pan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 24, 2015
Associations of polymorphisms in microRNAs with female breast cancer risk in Chinese populationBangshun He, Yuqin Pan, Yeqiong Xu, et al.
Free Radical Biology & Medicine|September 12, 2025
Cigarette smoke disrupts osteogenic-adipogenic balance via Nrf2/HERC2 axis-driven ferroptosisWenjing Li, Li Song, Fanxuan Zhang, et al.
Molecular Therapy. Nucleic Acids|February 10, 2022
Novel insights into the interaction between N6-methyladenosine modification and circular RNATao Xu, Bangshun He, Huiling Sun, et al.
Oncology Letters|September 4, 2023
[Retracted] MicroRNA‑365b‑3p represses the proliferation and promotes the apoptosis of non‑small cell lung cancer cells by targeting PPP5CXiaomiao Zhang, Jin Wang, Yuqin Pan, et al.
Molecular Carcinogenesis|August 4, 2023
Integrated analysis of single cell and bulk RNA sequencing identifies CTHRC1+ INHBA+ CAF as drivers of colorectal cancer progressionShangshang Hu, Jian Qin, Rui Gao, et al.
Journal of Ethnopharmacology|June 8, 2025
Anemarrhena asphodeloides fructan attenuates cigarette smoke-induced muscle atrophy by activating the Akt/mTOR pathway and inhibiting the ubiquitin-proteasome pathwayLeqian Wang, Yuqin Pan, Bingfeng Lin, et al.
Pharmacogenomics and Personalized Medicine|November 6, 2020
Susceptibility of PON1/PON2 Genetic Variations to Ischemic Stroke Risk in a Chinese Han PopulationYuqin Pan, Bangshun He, Huiling Sun, et al.
Mutagenesis|June 10, 2011
Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studiesBangshun He, Ying Zhang, Yuqin Pan, et al.
Pageof 13